The purpose of this research study is to develop a database to better understand Charcot-Marie-Tooth disease (CMT). We will carefully measure changes in strength, sensation, and nerve conduction velocities, using non-invasive but state of the art technology, at intervals of approximately six months to one year for as long as you would like to continue being seen at our practice.
Individuals may also be eligible to enroll in our substudy, the Genetics of CMT. Genetic testing on a research basis is more thorough than commercial testing. People who are eligible include all people with CMT1A and families who have an unidentified form of CMT.
How understandable was the trial content above?
Hard to understand
Easy to understand
